Literature DB >> 22573076

Obesity, hypertension, and cardiovascular health: is there anything poor Cassandra tries to tell us?

Jens Jordan, Stefan Engeli.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22573076     DOI： 10.1097/HJH.0b013e3283542da0

Source DB:  PubMed          Journal:  J Hypertens        ISSN： 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  3 in total

1.  Randomized trial of perindopril, enalapril, losartan and telmisartan in overweight or obese patients with hypertension.

Authors:  Sergey V Nedogoda; Alla A Ledyaeva; Elena V Chumachok; Vera V Tsoma; Galina Mazina; Alla S Salasyuk; Irina N Barykina
Journal:  Clin Drug Investig       Date:  2013-08       Impact factor: 2.859

Review 2.  INTERACTING DISCIPLINES: Cardiac natriuretic peptides and obesity: perspectives from an endocrinologist and a cardiologist.

Authors:  Hugo R Ramos; Andreas L Birkenfeld; Adolfo J de Bold
Journal:  Endocr Connect       Date:  2015-09       Impact factor: 3.335

3.  Regulation of alternative splicing in obesity-induced hypertension.

Authors:  Zodwa Dlamini; Rodney Hull; Tshepiso J Makhafola; Mzwandile Mbele
Journal:  Diabetes Metab Syndr Obes       Date:  2019-08-28       Impact factor: 3.168
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.